Open Eye

A plain-language record of the U.S. government

substantiveOct 20, 2021 · House roll call · passage · Result: Passed

On Motion to Suspend the Rules and Pass, as Amended — H R 4369 — National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act

National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021

In plain language

  • House bill in the 117th Congress.
  • Directs the Food and Drug Administration (FDA) to designate qualified colleges (or consortia of such institutions) as National.
  • House passed it on Oct 20, 2021 (substantive).
Official summary (Congressional Research Service)

National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021 This bill directs the Food and Drug Administration (FDA) to designate qualified institutions of higher education (or consortia of such institutions) as National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing and to provide grants to the centers. Each designated center must conduct research on advanced and continuous pharmaceutical manufacturing technologies and must share information from such research with the FDA. (Currently, most drug production involves batch manufacturing, which typically takes longer than continuous manufacturing processes.)

View this measure on congress.gov

Roll-call breakdown

Yea368

Democrat: 217 · Republican: 151

Nay56

Republican: 56

Present0

Not Voting7

Democrat: 2 · Republican: 5

How each member voted (431)

Yea (368)

Nay (56)

Not Voting (7)

Party labels reflect each member’s most recent affiliation on record.